Company news
Fermentalg SA news in 2026
Fermentalg SA's news releases, calls and decks from 2026, newest first.
Revenue for the first half of 2026: EUR7.4 million // Growth in DHA sales in high value-added segments and first order of the natural blue colour
July 16, 2026
Successful completion of a nearly EUR11 million capital increase to accelerate commercial development
May 13, 2026
Launch of a capital increase with an indicative amount of approximately EUR10 million to accelerate commercial development
May 12, 2026
Launch of a capital increase with an indicative amount of approximately EUR10 million to accelerate commercial development
May 12, 2026
Success of the sales diversification strategy in the first quarter of 2026 and commercial launches of the new BioSolutions
May 5, 2026
Success of the sales diversification strategy in the first quarter of 2026 and commercial launches of the new BioSolutions
May 5, 2026
2025 Annual Results: Strong sales growth, expansion of the customer portfolio and BioSolutions, and strengthening of the financial structure thanks to Huvepharma
April 2, 2026
Fermentalg: EFSA’s favorable opinion on Fermentalg’s Galdieria Blue colorant paves the way for its commercialization in Europe
March 16, 2026
17% increase in revenue in 2025, strong acceleration expected in 2026 and financing for the business secured
January 28, 2026
2026 Financial Agenda
January 16, 2026